JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
JW (Cayman) Therapeutics Co. Ltd. has announced a change in its auditor, with Deloitte Touche Tohmatsu replacing PricewaterhouseCoopers due to a disagreement over audit fees. The transition to Deloitte is expected to maintain audit quality without disrupting the company’s financial reporting for the year ending December 31, 2024. This strategic move underscores the company’s commitment to aligning with industry standards and ensuring shareholder interests.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.
